Spots Global Cancer Trial Database for total lymphoid irradiation
Every month we try and update this database with for total lymphoid irradiation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy | NCT01807611 | Leukemia Lymphoma | Total Lymphoid ... Fludarabine Cyclophosphamid... Thiotepa Melphalan HPC,A Infusion TC-NK Infusion G-CSF Mesna CliniMACS Mycophenolate m... | - 21 Years | St. Jude Children's Research Hospital | |
| Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer | NCT01375023 | Breast Cancer | Radiotherapy Anti-Thymocyte ... | 18 Years - 70 Years | European Institute of Oncology | |
| Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies | NCT00476229 | Lymphoma Leukemia | Thymoglobulin Total Lymphoid ... Peripheral Bloo... Rituximab | - 70 Years | M.D. Anderson Cancer Center | |
| Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies | NCT00476229 | Lymphoma Leukemia | Thymoglobulin Total Lymphoid ... Peripheral Bloo... Rituximab | - 70 Years | M.D. Anderson Cancer Center | |
| Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation | NCT01081405 | HEMATOLOGIC MAL... | TOTAL LYMPHOID ... | 50 Years - 70 Years | Fondazione EMN Italy Onlus | |
| Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen | NCT02199041 | Hematological M... | Cyclophosphamid... Thiotepa Fludarabine Melphalan Mesna G-CSF Mycophenolate m... Tacrolimus Methylprednisol... Total lymphoid ... Lymphocyte infu... CliniMACS | - 21 Years | St. Jude Children's Research Hospital | |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome | NCT05139004 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Secondary Acute... | Allogeneic Hema... Basiliximab Fludarabine Pho... Indium In 111-D... Melphalan Palifermin Total Lymphoid ... Total Marrow Ir... Yttrium Y 90 Ba... | 60 Years - | City of Hope Medical Center | |
| Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG | NCT00899847 | Transplantation... Transplantation... Multiple Myelom... Blood and Marro... | Autologous peri... Allogeneic peri... Filgrastim Cyclophosphamid... Melphalan Cyclosporine Total lymphoid ... Rabbit anti-thy... Mycophenolate M... Solumedrol Diphenhydramine Acetaminophen Hydrocortisone | 18 Years - 75 Years | Stanford University | |
| Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation | NCT01081405 | HEMATOLOGIC MAL... | TOTAL LYMPHOID ... | 50 Years - 70 Years | Fondazione EMN Italy Onlus | |
| Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | NCT00186628 | Leukemia, Mast-... Mantle-cell Lym... | Total lymphoid ... Rituximab Anti-thymoglobu... Cyclosporine Mycophenylate m... Filgrastim Granisetron Solumedrol Acetaminophen Diphenhydramine Hydrocortisone | 18 Years - 76 Years | Stanford University | |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome | NCT05139004 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Secondary Acute... | Allogeneic Hema... Basiliximab Fludarabine Pho... Indium In 111-D... Melphalan Palifermin Total Lymphoid ... Total Marrow Ir... Yttrium Y 90 Ba... | 60 Years - | City of Hope Medical Center | |
| Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies | NCT00476229 | Lymphoma Leukemia | Thymoglobulin Total Lymphoid ... Peripheral Bloo... Rituximab | - 70 Years | M.D. Anderson Cancer Center | |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome | NCT05139004 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Secondary Acute... | Allogeneic Hema... Basiliximab Fludarabine Pho... Indium In 111-D... Melphalan Palifermin Total Lymphoid ... Total Marrow Ir... Yttrium Y 90 Ba... | 60 Years - | City of Hope Medical Center | |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome | NCT05139004 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Secondary Acute... | Allogeneic Hema... Basiliximab Fludarabine Pho... Indium In 111-D... Melphalan Palifermin Total Lymphoid ... Total Marrow Ir... Yttrium Y 90 Ba... | 60 Years - | City of Hope Medical Center | |
| Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies | NCT01566656 | Haemato-lymphoi... | total lymphoid ... | 50 Years - 66 Years | Nantes University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
